This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Related letters  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Nutritional and Metabolic Disorders  • Nutrition/ Malnutrition  • Macular Degeneration  • Diet  • Alert me on articles by topic  Social Bookmarking   What's this?

Niyati Parekh, PhD, RD(India); Richard J. Chappell, PhD; Amy E. Millen, PhD; Daniel M. Albert, MD; Julie A. Mares, PhD

Arch Ophthalmol. 2007;125(5):661-669.

Objective  To evaluate the associations between levels of vitamin D (25-hydroxyvitamin D) in serum and prevalent age-related macular degeneration (AMD).

Methods and Design  Cross-sectional associations of serum vitamin D and early and advanced AMD, assessed from nonmydriatic fundus photographs, were evaluated in the third National Health and Nutrition Examination Survey, a multistage nationally representative probability sample of noninstitutionalized individuals (N = 7752; 11% with AMD).

Results  Levels of serum vitamin D were inversely associated with early AMD but not advanced AMD. The odds ratio (OR) and 95% confidence interval (CI) for early AMD among participants in the highest vs lowest quintile of serum vitamin D was 0.64 (95% CI, 0.5-0.8; P trend <.001). Exploratory analyses were conducted to evaluate associations with important food and supplemental sources of vitamin D. Milk intake was inversely associated with early AMD (OR, 0.75; 95% CI, 0.6-0.9). Fish intake was inversely associated with advanced AMD (OR, 0.41; 95% CI, 0.2-0.9). Consistent use vs nonuse of vitamin D from supplements was inversely associated with early AMD only in individuals who did not consume milk daily (early AMD: OR, 0.67; 95% CI, 0.5-0.9).

Conclusion  This study provides evidence that vitamin D may protect against AMD. Additional studies are needed to confirm these findings.

Author Affiliations: The Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey, New Brunswick (Dr Parekh); Department of Ophthalmology and Visual Sciences (Drs Parekh, Albert, and Mares) and Department of Statistics and Biostatistics (Dr Chappell), University of Wisconsin–Madison, Madison; and Department of Social and Preventive Medicine, University at Buffalo, Buffalo, NY (Dr Millen).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Lutein/Zeaxanthin
W. Rex Hawkins
Arch Ophthalmol. 2008;126(9):1313.
EXTRACT | FULL TEXT  

Lutein/Zeaxanthin—Reply
John Paul SanGiovanni
Arch Ophthalmol. 2008;126(9):1313-1314.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lutein/Zeaxanthin--Reply
SanGiovanni
Arch Ophthalmol 2008;126:1313-1314.
FULL TEXT  

Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration
Augood et al.
Am. J. Clin. Nutr. 2008;88:398-406.
ABSTRACT | FULL TEXT  

Beneficial Effect of Zeaxanthin on Retinal Metabolic Abnormalities in Diabetic Rats
Kowluru et al.
IOVS 2008;49:1645-1651.
ABSTRACT | FULL TEXT